Literature DB >> 943801

The diagnostic value of hyperostosis in midline subfrontal meningioma.

K F Lee.   

Abstract

Roentgenologic analysis of 66 patients with proved midline subfrontal meningioma indicates a very high incidence of hyperostosis. A total of 63 patients (95%) showed varying degrees of hyperostosis involving the cribiform plate, planum sphenoidale, or tuberculum sellae (including the chiasmatic sulcus). The planum sphenoidale is the most common site of hyperostosis (59%). In 19 cases (29%), the region of hyperostosis did not correspond to the site of tumor attachment. Mild or localized hyperostosis may be apparent only on tomograms. Small "blistering" and "saw-tooth-like" osteoma formation are reliable early signs of midline subfrontal meningioma; conversely, midline subfrontal meningioma can be virtually ruled out if hyperostosis is absent.

Entities:  

Mesh:

Year:  1976        PMID: 943801     DOI: 10.1148/119.1.121

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Sarcoid-like disorder of the intracranial optic nerve.

Authors:  L Frisén; S Lindgren; B J MacGregor; S Stattin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-07       Impact factor: 10.154

2.  Correlating hemodynamic magnetic resonance imaging with high-field intracranial vessel wall imaging in stroke.

Authors:  Weston Langdon; Manus J Donahue; Anja G van der Kolk; Swati Rane; Megan K Strother
Journal:  J Radiol Case Rep       Date:  2014-06-30

3.  Rare multiple orbital localizations of sarcoidosis. A case report.

Authors:  E Signorini; E Cianciulli; E Ciorba; G P Pelliccioli; N Caputo; U Salvolini
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

4.  A 42-year-old woman with subacute reversible dementia: A cautionary tale.

Authors:  Joseph Kamtchum-Tatuene; Richard Kamwezi; Thokozani Nyalubwe; Josephine P Banda; Gloria Mwangalika; Ian Matandika; Ulla Hemmila; Magnus Tisell; Susanna Koponen; Laura A Benjamin; Patrick Kamalo
Journal:  Malawi Med J       Date:  2017-09       Impact factor: 0.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.